Development
Tarsus Pharmaceuticals, Inc.
TARS
$41.15
-$0.76-1.81%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 227.44M | 246.89M | 178.23M | 201.22M | 217.03M |
| Total Receivables | 17.71M | 6.37M | 246.00K | 2.92M | 3.58M |
| Inventory | 3.11M | 15.00K | -- | -- | -- |
| Prepaid Expenses | 7.87M | 6.01M | 5.00M | 4.51M | 4.77M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 256.13M | 259.28M | 183.48M | 208.65M | 225.38M |
|
|
|||||
| Total Current Assets | 256.13M | 259.28M | 183.48M | 208.65M | 225.38M |
| Net Property, Plant & Equipment | 3.35M | 3.63M | 3.68M | 1.73M | 1.53M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 3.87M | 3.97M | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.51M | 1.18M | 1.34M | 438.00K | 477.00K |
| Total Assets | 265.49M | 268.33M | 188.93M | 211.21M | 227.86M |
|
|
|||||
| Total Accounts Payable | 18.15M | 10.38M | 8.17M | 7.57M | 5.50M |
| Total Accrued Expenses | 13.52M | 8.67M | 6.16M | 4.97M | 9.21M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 398.00K | 423.00K | 431.00K | 703.00K | 721.00K |
| Total Finance Division Other Current Liabilities | 4.87M | 3.78M | -- | 14.00K | -- |
| Total Other Current Liabilities | 4.87M | 3.78M | -- | 14.00K | -- |
| Total Current Liabilities | 36.94M | 23.25M | 14.77M | 13.26M | 15.43M |
|
|
|||||
| Total Current Liabilities | 36.94M | 23.25M | 14.77M | 13.26M | 15.43M |
| Long-Term Debt | 29.82M | 29.71M | 24.61M | 24.52M | 19.43M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.52M | 1.67M | 1.82M | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 233.00K | 44.00K | 11.00K | 40.00K | 100.00K |
| Total Liabilities | 68.50M | 54.67M | 41.20M | 37.81M | 34.96M |
|
|
|||||
| Common Stock & APIC | 441.65M | 416.43M | 311.36M | 305.66M | 301.74M |
| Retained Earnings | -244.66M | -202.75M | -163.61M | -132.18M | -108.76M |
| Treasury Stock & Other | -2.00K | -8.00K | -23.00K | -70.00K | -74.00K |
| Total Common Equity | 196.99M | 213.66M | 147.73M | 173.40M | 192.90M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 196.99M | 213.66M | 147.73M | 173.40M | 192.90M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 196.99M | 213.66M | 147.73M | 173.40M | 192.90M |
|
|
|||||